CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 219 enrolled
Drug / intervention
CJC-TraCother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05376371
NCT05376371N/ACompleted
CompareCT.gov

Health Systems Innovations for Supporting Transitions of Care for Incarcerated People Living With HIV, Hepatitis C, and Substance Use Disorder

University of Wisconsin, Madison·interventional·Posted May 17, 2022·Updated Nov 17, 2025

In Brief

A clinical study evaluating CJC-TraC for HIV and 2 related conditions. Completed, enrolled 219 participants across 2 sites.

Detailed Summary

This project aims to enroll 220 incarcerated individuals living with HIV, Hepatitis C (HCV), or history of substance misuse preparing for release into a pilot implementation study to test the feasibility and acceptability of an adapted Coordinated Transitional Care intervention in a Criminal Justice setting (CJC-TraC). Participants can expect to be on study for up to 6 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV, Hepatitis C, Substance Use Disorders
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

N/ACompletedFinished
2023202420252026
First PostedMay 17, 2022
Enrollment StartNov 29, 2022
Primary CompletionDec 3, 2024
Study CompletionMar 31, 2025
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 4.1 years ago

Interventions

CJC-TraCother

CJC-TraC utilizes a nurse case manager (NCM) to coordinate the participant's transitional care through release from a correctional facility. The NCM will visit either in person or via telehealth with the participant up to 4 times while incarcerated, and up to 4 times after release.